Roth Capital Comments on Aurora Cannabis Q1 Earnings

Aurora Cannabis Inc. (TSE:ACB) – Analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for Aurora Cannabis in a note issued to investors on Thursday, February 6th. Roth Capital analyst W. Kirk expects that the company will post earnings per share of $0.24 for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2026 earnings at $0.03 EPS, Q3 2026 earnings at $0.57 EPS and Q4 2026 earnings at $0.41 EPS.

Aurora Cannabis (TSE:ACB) last announced its earnings results on Wednesday, November 6th. The company reported C$0.05 EPS for the quarter, topping analysts’ consensus estimates of C($0.30) by C$0.35. Aurora Cannabis had a negative return on equity of 6.13% and a negative net margin of 11.53%. During the same period in the previous year, the business posted ($0.70) earnings per share.

Other analysts also recently issued research reports about the stock. ATB Capital decreased their price objective on shares of Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of C$5.85.

Aurora Cannabis Trading Up 17.1 %

ACB stock opened at C$8.96 on Friday. The firm’s fifty day simple moving average is C$6.03 and its two-hundred day simple moving average is C$7.17. The stock has a market capitalization of C$489.75 million, a price-to-earnings ratio of -14.22 and a beta of 2.71. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95. Aurora Cannabis has a twelve month low of C$3.84 and a twelve month high of C$12.85.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.